Erin Kutz
Erin Kutz has a background in covering business, politics and general news. She holds a bachelor’s degree in journalism from Boston University. Erin previously worked in the Boston bureau of Reuters, where she wrote articles on the investment management and mutual fund industries. While in college, she researched for USA Today reporter Jayne O’Donnell’s book, Gen Buy: How Tweens, Teens and Twenty-Somethings Are Revolutionizing Retail. She also spent a semester in Washington, DC, reporting Capitol Hill stories as a correspondent for two Connecticut newspapers and interning in the Money section of USA Today, where she assisted with coverage on the retail and small business beats. Erin got her first taste of reporting at Boston University’s independent student newspaper, as a city section reporter and fact checker and editor of the paper’s weekly business section.
Recent posts
It’s been less than a year since Boston-Power, a lithium-ion battery maker, announced it had raised a whopping $125 million Series F funding round from Beijing-based GSR Ventures—and was moving... Read more »
Waltham, MA-based Care.com announced this morning that it nabbed $50 million in a Series E financing led by new investor Institutional Venture Partners. Return backers including Matrix Partners, New Enterprise Associates,... Read more »
You could say that Active Endpoints’ latest product release takes a bare essentials approach to enterprise mobility.
The Waltham, MA-based company was founded in 2003 and developed collaboration and workflow software... Read more »
Massachusetts governor Deval Patrick’s administration announced today that the state has pulled in $16.9 million in federal funding for its so-called health information exchange, which will enable healthcare providers, hospitals, and... Read more »
We’ve seen a mix of new life sciences players, funding announcements, acquisitions, and clinical trial updates this week in New England.
—My colleague Arlene profiled Cambridge, MA-based Thrombolytic Science International and its... Read more »
This last week’s New England deals spanned venture firms, biotechs, and mobile, social, and security software startups.
—Boston-based Brightcove (NASDAQ: BCOV), which provides hosting technology for digital content, signed an... Read more »
New York startup Coffee Meets Bagel is built around some of the biggest themes in online shopping innovation over the last few years: content curation, limited-time events, social recommendations, and daily... Read more »
Waltham, MA-based security software firm Bit9 is announcing today that it has brought in $34.5 million in Series D funding, led by new investor Sequoia Capital. Return backers Atlas Venture, Highland... Read more »
Earlier this week, Rhode Island-based Slater Technology Fund announced that it had backed VoltServer, a new startup out of the Ocean State, to the tune of $250,000.
Charlestown, RI-based VoltServer is... Read more »
We’ve seen deals in the past week involving New England software makers, health IT startups, and biotechs.
—Framingham, MA-based application performance management software maker Correlsense said it raised $3 million in... Read more »
This week’s New England life sciences news consisted of venture funding news, a research partnership, a health IT acquisition, and more.
—Alnylam Pharmaceuticals (NASDAQ: ALNY) saw its stock climb more... Read more »
Cambridge, MA-based Sermo, the provider of an online physician community, announced today that it has been acquired by New York-based healthcare insights company WorldOne. The purchase price of the deal was... Read more »
Mobile apps have grown so big that there’s now no shortage of companies selling software to help other companies build their own applications.
But Boston-based TourSphere is tackling a very specific... Read more »
Acquisitions, investments, new VC funds, and strategic partnerships have made up the New England deals news in the last week.
—Shareaholic, a Cambridge, MA-based maker of software for sharing and discovering... Read more »
Startup incubators have been multiplying so fast there’s talk of a bubble, and there’s no sign of slowdown anytime soon. Jenna Rose says the growth is justified and has come... Read more »
[Corrected 8/10/12, 7:30 pm. See below.] Thermo Fisher Scientific (NYSE: TMO), the Waltham, MA-based provider of lab tools and life sciences instruments, announced today that it has signed a definitive... Read more »
CEO news, clinical trials, startup financing, and boring biotech companies made up the New England life sciences news this week.
—Cambridge, MA-based Lantos Technologies, an MIT spinout working on 3D imaging technology... Read more »
[Updated 7/12/12, 10:50 am. See below.] It’s been a booming week for deals in New England, and that’s not even counting today…
—Morgenthaler Ventures led a $10 million Series... Read more »
This week’s New England deals news came from IT, mobile software, and medical prosthetic startups.
—Plexxi, the recently de-stealthed startup that’s looking to more efficiently connect applications in data centers with... Read more »
“Most of mobile right now is focused on trying to figure out where the whales are—the big dollar advertising,” says Jeffrey Peden. Seems to be an accurate statement, considering the big... Read more »
